Forskolin, extracted from the root of Coleus forskohlii, has a long history in weight-management supplements abroad, and brands ask for it by name expecting a routine formulation. Japan permits it as a food ingredient, but it is one of a small number of botanicals singled out under a 2020 legal change that requires a specific warning label, after digestive-reaction reports.
This guide covers that requirement, what the human trials on body composition actually show, and how to formulate a compliant product.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a forskolin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
Forskolin’s status in Japan
Coleus forskohlii is permitted as a food ingredient in Japan, but since June 2020 it has been designated a substance requiring special attention (指定成分等) under the Food Sanitation Act, which carries a mandatory warning label and a manufacturer reporting duty.
Coleus forskohlii sits on Japan’s list of substances not judged to be pharmaceutical, so a factory can manufacture it as a food provided no medicinal claims are made. Separately, a June 2020 revision to the Food Sanitation Act created a new category of “designated ingredients” (指定成分等) for substances with a history of reported health-damage cases that nonetheless remain legal as foods. Coleus forskohlii was placed in that category following multiple reports of digestive reactions linked to diet products containing it.
In practice, this means a Japan-made Coleus forskohlii product must:
- Carry a specific warning statement on the label, as required for all designated-ingredient products, alongside the standard food-supplement labelling.
- Be covered by a manufacturer process for collecting and reporting health-damage information, which a Japanese GMP factory and its quality system need to support.
- Correctly disclose the ingredient on the ingredient list. A 2021 voluntary recall in Japan was issued specifically because two diet products containing Coleus forskohlii omitted both the ingredient disclosure and the required warning label — the products themselves had not been linked to a reported health incident at the time.
💬 Need the designated-ingredient warning label and reporting requirements built into your formulation and labelling plan from the start? Tell us your concept.
What the research shows
Small randomised, placebo-controlled trials of Coleus forskohlii extract report mixed results for body composition, with reductions in body fat percentage in some trials but no consistent effect on total body weight.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Randomised, double-blind, placebo-controlled trial, Obesity Research 2005, 13:1335–1343 (PMID 16129715) | 30 overweight or obese men, forskolin extract or placebo, 12 weeks | Forskolin group showed a significant decrease in body fat percentage and fat mass (measured by DXA) versus placebo, and an increase in serum free testosterone versus placebo; body weight itself was not significantly different between groups |
| Randomised controlled trial, Nutrients 2015, 7(11):9508–9522 (PMC4663611) | 30 overweight or obese adults, Coleus forskohlil extract alongside a reduced-calorie diet, 12 weeks | Both the extract and placebo groups, all following a hypocaloric diet, showed significant reductions in waist and hip circumference, with no clear extra benefit attributed to the extract itself over diet alone for these measures |
Caveats worth keeping in view:
- Trial sizes are small, around 30 participants each, and results are mixed between studies rather than consistently positive.
- Neither trial showed a clear, consistent reduction in total body weight from the extract beyond what diet alone produced in the comparison trial.
- The 2005 trial’s testosterone finding is a secondary hormonal measurement, not a sexual-health outcome, and should not be read as evidence for any sexual-function claim.
Checked against the published abstracts on 25 September 2026.
Wording that stays on safe ground
Describe forskolin by what the small trials measured, without implying a settled weight-loss result or omitting the mandatory warning.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for body composition alongside diet, with mixed results across trials" | "Melts fat” or a guaranteed weight-loss claim |
| The designated-ingredient warning label, displayed as required | Marketing copy that could be mistaken for, or that crowds out, the mandatory warning |
| ”Contains Coleus forskohlii extract” with the amount per serving | Digestive-tolerance claims that go beyond what the trials measured |
How forskolin is formulated
Coleus forskohlii is supplied as a standardised root extract, and in Japan the specification must build in the designated-ingredient warning label and reporting process from the start.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Capsule | Standard format for standardised extracts | Fill weight depends on extract standardisation |
| Tablet | Compact, combines easily with other weight-management ingredients | Warning label space needed on pack alongside standard claims |
Decisions that shape the specification:
- Extract standardisation. Coleus forskohlii extracts are typically standardised to a percentage of the active compound; confirm the specification matches the dose used in the trial you intend to reference.
- Amount per serving. Match the amount to the dose range used in the trials above, and disclose it clearly.
- Labelling and reporting. Build the designated-ingredient warning label and your manufacturer’s health-damage reporting process into the specification before production, not after.
- Your market’s status for forskolin. Its status as a food ingredient, and any warning-label requirements, differ between countries. Confirm before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product — Coleus forskohlii clears this check, but with an added labelling and reporting obligation most ingredients do not carry.
See the Japan-made supplement OEM page for how we check a full formula and its labelling requirements before quoting, and compare with our L-carnitine and green tea catechin guides.
Before you ask for a quotation
A factory can quote accurately once the extract standardisation, the amount, the warning-label plan and the packaging are fixed.
- Coleus forskohlii extract standardisation and source documentation
- Amount per serving and servings per pack
- Designated-ingredient warning-label placement on your pack design
- Companion ingredients and their amounts
- Countries you will sell in, and forskolin’s status and any warning requirements there
- First order and annual volume
💬 Ready to design a Japan-made forskolin product? Send us the concept — extract standardisation, amount, warning-label plan and the countries you will sell in.
Frequently asked questions
1. Can a Japanese factory make a forskolin product?
Yes. Coleus forskohlii is permitted as a food ingredient in Japan. Since June 2020 it has also been designated a substance requiring special attention (指定成分等), which adds a mandatory warning label and a manufacturer health-damage reporting duty on top of standard food-supplement rules.
2. Why does forskolin carry this extra requirement?
Japan’s Ministry of Health, Labour and Welfare created the designated-ingredient category after multiple reports of digestive reactions, including diarrhoea and vomiting, linked to diet products containing Coleus forskohlii. The category keeps the ingredient legal as a food while requiring closer monitoring.
3. Does the research show forskolin causes weight loss?
The evidence is mixed. A 2005 trial found reduced body fat percentage but no significant total-weight difference; a 2015 trial found circumference reductions in both the extract and placebo groups, all following the same reduced-calorie diet, with no clear extra benefit shown for the extract on those measures.
4. What happens if the warning label is left off?
A 2021 case in Japan led to a voluntary recall of two diet products because they omitted both the Coleus forskohlii ingredient disclosure and the required warning label, even though no health incident had been reported for those specific products at the time.
5. What should I decide before asking for a quotation?
The extract standardisation, the amount per serving, how the designated-ingredient warning label fits your pack design, any companion ingredients, and the countries you plan to sell in.
Sources: Japan Ministry of Health, Labour and Welfare, designated ingredients (指定成分等) list under the revised Food Sanitation Act, effective June 2020, including Coleus forskohlii; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), safety and efficacy information page on Coleus forskohlii (hfnet.nibn.go.jp), reported digestive adverse effects including diarrhoea and vomiting; NIBIOHN alert on a July 2021 voluntary product recall for undisclosed Coleus forskohlii content and missing warning label; “Body Composition and Hormonal Adaptations Associated with Forskolin Consumption in Overweight and Obese Men”, Obesity Research 2005, 13:1335-1343, PMID 16129715; “Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial”, Nutrients 2015, 7(11):9508-9522, PMC4663611. Checked on 25 September 2026.